Class Period: Apr 30, 2015 to Oct 27, 2016
Lead Plaintiff Deadline: Mar 13, 2017
Summary of Case:
A securities class action has been filed against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO") on behalf of investors in Novo Nordisk American Depositary Receipts ("ADR") during the time period of April 30, 2015 to October 27, 2016. This case has been filed in the USDC - New Jersey.
The Complaint alleges that during the Class Period, Novo Nordisk reported materially false and misleading earnings and forecasts in that they were inflated through the collusive price fixing of the Company's insulin drugs. The Complaint also alleges that Novo Nordisk misrepresented and concealed the true extent of the pricing pressures it was experiencing from pharmacy benefit managers.
If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.